Journal of Cell Science partnership with Dryad

Journal of Cell Science makes data accessibility easy with Dryad

RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFR
Kavitha Balaji, Chelsea Mooser, Christine M. Janson, Joanne M. Bliss, Houmehr Hojjat, John Colicelli


Stimulation of epidermal growth factor receptor (EGFR) initiates RAS signaling simultaneously with EGFR internalization. Endocytosed EGFR is then either recycled or degraded. EGFR fate is determined in part by the RAS effector RIN1, a guanine nucleotide exchange factor (GEF) for RAB5 GTPases. EGFR degradation was slowed by RIN1 silencing, enhanced by RIN1 overexpression and accelerated by RIN1 localization to the plasma membrane. RIN1 also directly activates ABL tyrosine kinases, which regulate actin remodeling, a function not previously connected to endocytosis. We report that RIN1-RAB5 signaling favors EGFR downregulation over EGFR recycling, whereas RIN1-ABL signaling stabilizes EGFR and inhibits macropinocytosis. RIN1QM, a mutant that blocks ABL activation, caused EGF-stimulated membrane ruffling, actin remodeling, dextran uptake and EGFR degradation. An ABL kinase inhibitor phenocopied these effects in cells overexpressing RIN1. EGFR activation also promotes RIN1 interaction with BIN1, a membrane bending protein. These findings suggest that RIN1 orchestrates RAB5 activation, ABL kinase activation and BIN1 recruitment to determine EGFR fate.


  • Funding

    This work was supported by the National Institutes of Health [grant number CA136699 to J.C.]; the UCLA Jonsson Comprehensive Cancer Center (to J.C.); the Ruth L. Kirschstein National Research Service Award [grant number GM007185 to C.J. and J.M.B.]; and the Whitcome Training Fellowship (to K.B.). Deposited in PMC for release after 12 months.

  • Supplementary material available online at

  • Accepted August 1, 2012.
View Full Text